Cargando…
C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer
Core 1 β1,3-galactosyltransferase (C1GALT1) controls the crucial step of GalNAc-type O-glycosylation and is overexpressed in various human malignancies. However, its role in head and neck squamous cell carcinoma (HNSCC) remains unclear. Here we demonstrate that C1GALT1 expression is upregulated in H...
Autores principales: | Lin, Mei-Chun, Chien, Pin-Hui, Wu, Hsin-Yi, Chen, Syue-Ting, Juan, Hsueh-Fen, Lou, Pei-Jen, Huang, Min-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202324/ https://www.ncbi.nlm.nih.gov/pubmed/29930379 http://dx.doi.org/10.1038/s41388-018-0375-0 |
Ejemplares similares
-
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
por: Lee, Po-Chu, et al.
Publicado: (2020) -
C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma
por: Lin, Neng-Yu, et al.
Publicado: (2022) -
High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia
por: Ren, Zhihong, et al.
Publicado: (2022) -
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α(v)
por: Kuo, Ting-Chun, et al.
Publicado: (2021) -
B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma
por: Han, Yang, et al.
Publicado: (2022)